SUPERFLUID DX
Superfluid is building a translational science and data analysis platform to harness the power of cell-free mRNA to diagnose neruo-degenerative and other diseases.
SUPERFLUID DX
Industry:
Biotechnology
Address:
South San Francisco, California, United States
Country:
United States
Website Url:
http://www.superfluiddx.com
Status:
Active
Technology used in webpage:
Euro Google Maps Cloudflare Hosting Google Maps API Google Maps For Work
Similar Organizations
Cytokinetics
Cytokinetics is a biopharmaceutical company developing therapies for debilitating diseases.
DataZymes
Catalyzing Innovation in Pharma with Data-driven Digital Products
Group K Diagnostics
We put patient health 1st by revolutionizing rapid blood testing with a hand-held chemistry and ID analyzer for everyone, all in one.
Longevity Biotech
Longevity Biotech develops a new class of therapeutics via artificial protein technology that focuses on pharmaceutical preparation.
National Institutes of Health
National Institutes of Health is a biomedical research facility that focuses on biomedical and health-related research.
Nephron Pharmaceuticals
Nephron Pharmaceuticals Corporation is a mid-sized company that manufactures generic respiratory medications.
SF17 Therapeutics
SF17 Therapeutics is a precision medicine analytics platform.
Stryker
Stryker is a medical technology company that offers products and services in orthopaedics.
Vivli
Vivli is a clinical research data sharing platform.
Wright Medical Group
Wright Medical Group is an international medical device company specializing in extremities and biologics.
Investors List
WRQ Sciences
WRQ Sciences investment in Series A - Superfluid Dx
Official Site Inspections
http://www.superfluiddx.com
- Host name: 1410646.cloudwaysapps.com
- IP address: 165.227.236.179
- Location: London United Kingdom
- Latitude: 51.5353
- Longitude: -0.6658
- Timezone: Europe/London
- Postal: SL1
More informations about "Superfluid Dx"
About Us - Superfluid
Gajus was the COO of the Chan Zuckerberg Biohub where he led the development and growth of the organization for nearly five years. He is a Co-Founder of Kaizen Therapeutics, developing broad-spectrum antivirals and …See details»
Home - Superfluid
We need a revolution in diagnostics to match the recent innovations in therapeutics and treatments. cf-mRNA can detect neurodegenerative disease, including Alzheimers, at its …See details»
Superfluid Dx - Crunchbase Company Profile & Funding
Superfluid is building a translational science and data analysis platform to harness the power of cell-free mRNA to diagnose neruo-degenerative and other diseases.See details»
Superfluid DX 2025 Company Profile: Valuation, Funding
Superfluiddx.com. Formerly Known As. Molecular Stethoscope. Ownership Status. Privately Held (backing) Financing Status. Venture Capital-Backed. Corporate Office. 259 East Grand …See details»
Superfluid Dx, Inc. | LinkedIn
Superfluid Dx, Inc. | 140 followers on LinkedIn. Superfluid is developing the first high-performance, blood-based test for Alzheimer’s Disease (AD) and related dementias off of a …See details»
Superfluid Dx, Inc. - The Org
Superfluid is developing the first high-performance, blood-based test for Alzheimer’s Disease (AD) and related dementias off of a platform technology of cell-free mRNA analysis. This next …See details»
Superfluid Company Profile | Management and Employees List
Www.superfluiddx.com . Superfluid Profile and History. Based in San Francisco, California, Superfluid is a medtech company and diagnostics services provider with a focus on …See details»
Superfluid Dx - VentureRadar
Website: https://www.superfluiddx.com. Develops molecular biology, bioinformatics, and drug development technologies, leveraging cf-mRNA to create clinically useful diagnostic tests and …See details»
Superfluid Dx | Alzheimer's Drug Discovery Foundation
Apr 7, 2022 View all funding to this organization (1) View all funding to this investigator (1) GET IN TOUCH. [email protected]; 212.901.8000; Alzheimer's Drug Discovery Foundation. …See details»
Superfluid Dx, Inc. Overview | SignalHire Company Profile
Superfluid is developing the first high-performance, blood-based test for Alzheimer’s Disease (AD) and related dementias off of a platform technology of cell-free mRNA analysis. This next …See details»
SUPERFLUID - Company Profile - Tracxn
Feb 21, 2025 Email ID: *****@superfluiddx.com; Key Metrics. Latest Funding Round. Series A, Dec 21, 2023, Undisclosed. Investors. WRQ Sciences & 2 more. Ranked. 70 th among 698 …See details»
Superfluid Dx - Crunchbase Company Profile & Funding
Tissue-specific cell-free circulating RNA is a newly developed area for molecular diagnosis. Based on this powerful non-invasive approach, Molecular Stethoscope aims to transform healthcare …See details»
Careers - Superfluid
The estimated salary range for this role is $160,000- $190,000 and is based on a number of factors including experience and qualifications. This role also includes meaningful pre-IPO …See details»
Superfluid - Overview, News & Similar companies | ZoomInfo.com
View Superfluid (superfluiddx.com) location in California, United States , revenue, industry and description. Find related and similar companies as well as employees by title and much more.See details»
WRQ Sciences and Superfluid Dx., Inc. Announce Completion of ...
Dec 20, 2023 WRQ Sciences and Superfluid Dx, Inc., announced today the completion of an oversubscribed Series A financing led by WRQ Sciences. With this transaction, WRQ …See details»
WRQ Sciences and Superfluid Dx., Inc. Announce Completion of ...
Dec 20, 2023 More Accurate Test expected to become Indispensable Tool for Clinical Practice. PALO ALTO, Calif., Dec. 20, 2023 /PRNewswire/ -- WRQ Sciences and Superfluid Dx, Inc., …See details»
Foundation's(ADDF)DiagnosticsAccelerator(DxA ... - Superfluid
WRQSciencesandSuperfluidDx.,Inc.AnnounceCompletionofOversubscribedSeriesA FinancinginBreakthroughAlzheimer’sDiseaseDiagnosticCompanySuperfluidDx.See details»
WRQ Sciences and Superfluid Dx., Inc. Announce Completion of
Dec 20, 2023 More Accurate Test expected to become Indispensable Tool for Clinical Practice. PALO ALTO, Calif., Dec. 20, 2023 /PRNewswire/ -- WRQ Sciences and Superfluid Dx, Inc., …See details»
Superfluid Dx - Leveraging cf-mRNA for early disease detection
SuperfluidDx – Leveraging cf-mRNA for early disease detection At Premji Invest, we are excited to partner with companies that webelieve have uncommon potential.Our evergreen and long …See details»
Technology - Superfluid
Koh W, et al. (2014) Noninvasive in vivo monitoring of tissue-specific global gene expression in humans. PNAS 111(20):7361–7366.See details»